Topiramate Tablet, Film Coated
Product Images NDC 71205-233

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71205-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (A9eed983 Edf1 4f44 A8ec 568a52f03015 01)

Structured Product Formula For Topiramate (A9eed983 Edf1 4f44 A8ec 568a52f03015 01)
Chemical structure diagram of topiramate, showing its molecular framework with various oxygen, sulfur, nitrogen, and carbon atoms interconnected. The image depicts stereochemistry with specific bond orientations indicated.*
FDA Label Image

Structured Product Formula For Topiramate (A9eed983 Edf1 4f44 A8ec 568a52f03015 02)

Structured Product Formula For Topiramate (A9eed983 Edf1 4f44 A8ec 568a52f03015 02)
Kaplan-Meier estimate chart showing cumulative rates for time to first seizure over approximately 500 days. The graph compares two daily doses of topiramate, 50 mg/day and 400 mg/day, with cumulative rates increasing over time. The 50 mg/day group shows higher cumulative rates than the 400 mg/day group, with statistical significance indicated by P = 0.0002.*
FDA Label Image

Topiramate Tablets Usp (A9eed983 Edf1 4f44 A8ec 568a52f03015 03)

Topiramate Tablets Usp (A9eed983 Edf1 4f44 A8ec 568a52f03015 03)
Bar graph comparing the change from baseline to double-blind phase in average monthly migraine period rate with topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day versus placebo. Two studies are shown with separate bars for each dose, indicating decreases in migraine rates, with statistical significance noted for higher doses (100 mg/day and 200 mg/day).*
FDA Label Image

71205-233-60 (A9eed983 Edf1 4f44 A8ec 568a52f03015 04)

71205-233-60 (A9eed983 Edf1 4f44 A8ec 568a52f03015 04)
This is a prescription drug label for Topiramate 25 mg tablets by Proficient Rx LP. The label indicates a package size of 60 tablets, oral route, film-coated, round-shaped with beveled edges, and debossed with "ZD 16" on one side. Manufacturer is Cadila Healthcare Ltd., Ahmedabad, India. Storage instructions specify 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.